These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3161636)

  • 41. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Measles in Poland in the years 1962-1968 as viewed against the background of the epidemiologic situation throughout the world].
    Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1970; 24(1):1-14. PubMed ID: 5431386
    [No Abstract]   [Full Text] [Related]  

  • 43. [Measles in the Local Health Unit Naples 4: vaccination coverage, epidemic 2001-2002 and prevention strategies].
    Gigli L; Graziano M; Manetta G; Palombino R
    Ann Ig; 2004; 16(5):627-32. PubMed ID: 15552728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination in pulses: a strategy for global eradication of measles and polio?
    Nokes DJ; Swinton J
    Trends Microbiol; 1997 Jan; 5(1):14-9. PubMed ID: 9025230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measles: who pays the cost?
    Hastings A; Hostler A; Solen A
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1527-8. PubMed ID: 3111623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of questionnaire in a surveillance program of measles].
    Markvart K; Sejda J; Pecenka J; Srpová E; Vrabcová J; Strauss J; Zdrazílek J
    Cesk Epidemiol Mikrobiol Imunol; 1969 Mar; 18(2):82-9. PubMed ID: 4238403
    [No Abstract]   [Full Text] [Related]  

  • 47. Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts.
    Costa A; Henao-Restrepo AM; Marie Hall S; Jarrett S; Hoekstra EJ
    J Infect Dis; 2003 May; 187 Suppl 1():S22-8. PubMed ID: 12721888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles].
    Heidel G; Olbricht H; Ely K; Henkler J
    Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088
    [No Abstract]   [Full Text] [Related]  

  • 49. Measles: going, going, gone?
    Gill D
    Ir Med J; 1986 Jul; 79(7):174-5. PubMed ID: 3744751
    [No Abstract]   [Full Text] [Related]  

  • 50. [Vaccination against measles].
    Flugsrud L
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):132-4. PubMed ID: 5539604
    [No Abstract]   [Full Text] [Related]  

  • 51. Progress toward global measles control and regional elimination, 1990-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Dec; 47(48):1049-54. PubMed ID: 9869078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Med J Malaysia; 1985 Dec; 40(4):281-8. PubMed ID: 3842727
    [No Abstract]   [Full Text] [Related]  

  • 53. [Epidemiology and prevention of measles in the United States: 30 years of vaccination].
    Chauvin P
    Rev Epidemiol Sante Publique; 1995; 43(1):61-71. PubMed ID: 7892518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Measles at the Child Clinic in Sombor with special reference to measles vaccination].
    Gombosev-Mandić N
    Med Pregl; 1972; 25(1):45-8. PubMed ID: 5028334
    [No Abstract]   [Full Text] [Related]  

  • 55. [Measles 1982].
    Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1984; 38(2):99-106. PubMed ID: 6505246
    [No Abstract]   [Full Text] [Related]  

  • 56. Measles--United States, first 26 weeks, 1984.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Sep; 33(35):495-6, 501-4. PubMed ID: 6433163
    [No Abstract]   [Full Text] [Related]  

  • 57. Update on the elimination of measles in Canada, 1998.
    Litt M; Waters J
    Can Commun Dis Rep; 1999 Mar; 25(5):42-4. PubMed ID: 10095292
    [No Abstract]   [Full Text] [Related]  

  • 58. [Eradication of measles. Strategies of the Autonomous Community of Galicia].
    Farjas Abadía P
    Rev Esp Salud Publica; 1999; 73(5):629-33. PubMed ID: 10650755
    [No Abstract]   [Full Text] [Related]  

  • 59. Progress in the control of measles in Ghana, 1980-2000.
    Bosu WK; Essel-Ahun M; Adjei S; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S44-50. PubMed ID: 12721890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Estimation, in epidemic conditions, of the epidemiologic effectiveness of measles vaccination in administrative sector No. 3 of the city of Bucharest in 1986].
    Nedelcu NI; Mihăileanu C; Dobrescu A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(4):305-9. PubMed ID: 3441729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.